Mondelez International heads into the final stretch before its July 28 earnings report with options positioning the most defensively skewed it has been in months — even as short sellers quietly pull back.
The clearest signal this week is in options. The put/call ratio has climbed to 1.04, more than two standard deviations above its 20-day average of 0.93 — the highest z-score reading in the recent window. That's a meaningful shift for a consumer staples name that typically attracts modest hedging demand. The move stands out against the past month of history: the PCR tracked in a narrow range around 0.88–0.97 through May and early June before jumping sharply in the past two sessions. Investors are paying noticeably more for downside protection as the Q2 print approaches. Short interest, by contrast, tells a less crowded story. Bears have been covering steadily — short interest has dropped roughly 6% over the past month to 2.45% of the float, a low reading by any measure. Borrowing costs remain negligible at 0.49%, and availability is extraordinarily loose, with shares available to borrow running at more than 7,000% of shares currently short. There is essentially no constraint on new shorts building positions, yet they haven't. The setup is one of selective caution through options rather than any broad bear thesis in the lending market.
The Street entered this week broadly constructive on MDLZ. Following the Q1 beat in late April — which drove a 6.3% one-day move and a 6.9% five-day gain — multiple analysts lifted targets, with JP Morgan moving to $70, Evercore ISI to $71, and Barclays to $68. All maintained positive ratings. That cluster of post-earnings upgrades left the consensus at "buy" with a mean target of $67.21, against a current price of $61.06, implying roughly 10% upside. The valuation picture is modest rather than stretched: the stock trades at about 18.7x earnings and 13.8x EV/EBITDA, with both multiples compressing slightly over the past month. The ORTEX short score is an unremarkable 34.9 — near the middle of its recent range — while the dividend factor score ranks in the 90th percentile, reflecting the company's consistent income profile.
Bulls point to Mondelez's deep emerging-market footprint, the durability of brands like Oreo and Cadbury, and a track record of distribution gains in markets like India and Brazil. Bears flag the structural challenge: cocoa inflation has compressed margins, pricing power is limited in markets where sugar taxes and cost sensitivity constrain pass-through, and volume softness in North America and Europe has yet to fully resolve. Those tensions make the July 28 report more than a routine check-in.
The earnings reaction history adds context without offering a clear pattern. The most recent Q2-equivalent print produced barely a quarter-point move the next day, while the Q1 release this April drove the sharpest one-day gain in recent memory. Peer performance this week has been mixed but broadly weak — KHC fell 6.3% on the week, CPB dropped 4.9%, while GIS managed a small gain of 0.5%. MDLZ's own 1.8% weekly decline sits in the middle of that pack, suggesting sector-level pressure rather than a name-specific story.
The July 28 report is therefore the pivot. Whether the current put-buying proves prescient or simply reflects pre-earnings housekeeping will depend heavily on management's commentary around cocoa cost trajectories and any update on volume trends in North America — the two variables the bear case rests on most heavily.
See the live data behind this article on ORTEX.
Open MDLZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
